Navigation Links
2008 Lifetime Achievement Award in Heart Failure Presented During HFSA Annual Scientific Meeting

Heart Failure Society of America Honors Michael R. Bristow, M.D., Ph.D.

TORONTO, Sept. 22 /PRNewswire/ -- The Heart Failure Society of America (HFSA) announced today that Michael Bristow, M.D., Ph.D., Professor of Medicine (Cardiology) and the Co-Director of the University of Colorado Cardiovascular Institute, is the recipient of the Society's 2008 Lifetime Achievement Award. The award was presented to Bristow at the Opening Plenary Session of the HFSA 12th Annual Scientific Meeting, Sept. 21-24, 2008 at the Metro Toronto Convention Centre in Toronto, Ontario, Canada.

"The HFSA's Lifetime Achievement Award is given each year to a clinician or researcher who has advanced the awareness and treatment of heart failure throughout their career," said Dr. Barry Greenberg, HFSA President, and Professor of Medicine, and Director, Advanced Heart Failure Treatment Program, University of California, San Diego. "Dr. Bristow has made many significant contributions to the field of heart failure and we are honored to present him with this award."

Dr. Bristow received his MD in 1970 from the University of Illinois in Chicago, where he also earned a PhD in pharmacology the following year. After completing an NIH postdoctoral fellowship in pharmacology at the University of Illinois, he received his medical training at Stanford University, including an internship in internal medicine, a research fellowship in medicine/oncology, and a residency in medicine. He remained at Stanford to complete a fellowship in cardiology, where he joined the Cardiology faculty in 1979. He moved to the University of Utah in 1984, where he co-founded the first multi-hospital heart transplant program in the U.S. Dr. Bristow is board certified in internal medicine and in the subspecialty of cardiovascular diseases.

Dr. Bristow has authored more than 350 peer-reviewed papers and book chapters on heart failure and other cardiovascular diseases. He was instrumental in elucidating key molecular mechanisms underlying heart failure and the use of beta-blockers for its treatment, and in developing the first pharmacogenetically targeted cardiovascular drug (bucindolol, Gencaro(TM)), currently under consideration for FDA approval.

He has received many academic and industry honors, including the Therapeutic Frontiers Award, presented by the American College of Clinical Pharmacy, for development of beta-blockade as a treatment for chronic heart failure, and in 2008 the Pharmaceutical Research and Manufacturers of America Clinical Trial Exceptional Service Award for the development of carvedilol for heart failure. In 1999, he was ranked by Science Watch, as first among heart failure investigators in impact of cardiovascular publications between 1993 and 1997, and he is an original member (2002) of the Institute of Scientific Information's Highly Cited Researchers.

The purpose of the HFSA Lifetime Achievement Award, to be given at the HFSA Annual Scientific Meeting, is to recognize an individual who has made a significant and sustained contribution to the field of heart failure in terms of its scientific understanding, epidemiology or clinical care, or for his or her exemplary leadership or inspiration to others resulting in an important impact on the field.

About Heart Failure

Heart failure is a progressive condition in which the heart muscle becomes weakened after it is injured from heart attack or high blood pressure and gradually loses its ability to pump enough blood to supply the body's needs. Many people are not aware they have heart failure because the symptoms are often mistaken for signs of getting older. Heart failure affects from 4.6 to 4.8 million individuals in the United States. Demographic and clinical evidence strongly suggest the prevalence of heart failure will increase throughout the next decade. Ten to 15 years ago heart failure was considered a "death sentence;" however, recent advances in treatment have shown that early diagnosis and proper care in early stages of the condition are key to slowing, stopping or in some cases reversing progression, improving quality of life, and extending life expectancy. For more information on heart failure, please visit

About the Heart Failure Society of America

The Heart Failure Society of America (HFSA) is a nonprofit educational organization, founded in 1994 as the first organized association of heart failure experts. Today HFSA has over 1,700 members and provides a forum for all those interested in heart function, heart failure research and patient care. The Society also serves as a resource for governmental agencies (FDA, NIH, NHLBI, CMS). The HFSA Annual Scientific Meeting is designed to highlight recent advances in the development of strategies to address the complex epidemiological, clinical and therapeutic issues of heart failure. Additional information on HFSA can be found at

SOURCE The Heart Failure Society of America
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Reid Supply Introduces Lifetime Warranty on New Line of Hand Tools
2. Seniors Gain Experiences of a Lifetime
3. Individual Genome Changes Over a Lifetime
4. New PurinaCare(TM) Pet Health Insurance Helps Offer Dogs and Cats a Lifetime of Health and Happiness
5. Lifetime Medical Organizer
6. After Collecting 22 Million Petition Signatures on, Bipartisan Breast Cancer Patient Protection Act Gets First Congressional Hearing in 12 Years
7. Familial Breast Cancer Risk Lasts a Lifetime for Sisters
8. Lifetime Television Proudly Announces October Marquee Event Original Movie, Living Proof Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr.
9. NAMI: Women and Depression; 1 in 8 in Their Lifetime; Twice the Rate of Men
10. African Journey of a Lifetime With Alicia Keys! - Documentary Follows Keep a Child Alives Outreach to Communities Affected With HIV/AIDS
11. AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM)
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to ... Fortunately, an inventor from Austin, Texas, has identified a solution. , She developed a ... or restricted lighting. As such, it eliminates the need to turn on a light ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & ... and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to ... with elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
(Date:10/10/2017)... 2017  NDS received FDA 510(k) clearance in May 2017 for ... stand specifically designed for endoscopy environments. An innovative secondary monitor solution, ... solution to support the improvement of patient outcomes, procedural efficiency, and ... ... ...
(Date:10/7/2017)... , Oct. 6, 2017   Provista, a ... than $100 billion in purchasing power, today announced a ... information. The Newsroom is the online home ... trends, infographics, expert bios, news releases, slideshows and events. ... to a wealth of resources at their fingertips, viewers ...
Breaking Medicine Technology: